ETH 416 (Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U)

Generic Name: pancrelipase

Pill imprint ETH 416 has been identified as Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U.

Plaretase is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U is not subject to the Controlled Substances Act.

See also related documents.

Images for ETH 416 (Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U)

Plaretase Lipase 8,000 U / Amylase 30,000 U /  Protease 30,000 U ETH 416
Plaretase
Generic Name:
pancrelipase
Imprint:
ETH
416
Strength:
Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U
Color:
Tan
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Ethex Corporation
National Drug Code (NDC):
58177-0416

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)